(XHE) SPDR S&P Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A5810 • Health
XHE: Medical, Devices, Equipment, Supplies, Diagnostics, Instruments
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI). ‣ Company URL: http://www.spdrs.com ‣ Domicile: United States
Additional Sources for XHE ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XHE ETF Overview
| Market Cap in USD | 213m |
| Category | Health |
| TER | 0.35% |
| IPO / Inception | 2011-01-26 |
XHE ETF Ratings
| Growth 5y | 2.44% |
| Fundamental | - |
| Dividend | 35.6% |
| Rel. Strength Industry | -59.5 |
| Analysts | - |
| Fair Price Momentum | 85.57 USD |
| Fair Price DCF | - |
XHE Dividends
| Dividend Yield 12m | 0.03% |
| Yield on Cost 5y | 0.04% |
| Annual Growth 5y | 100.00% |
| Payout Consistency | 45.0% |
XHE Growth Ratios
| Growth Correlation 3m | 31.2% |
| Growth Correlation 12m | 74.9% |
| Growth Correlation 5y | -41.1% |
| CAGR 5y | 1.67% |
| CAGR/Mean DD 5y | 0.08 |
| Sharpe Ratio 12m | 0.46 |
| Alpha | -16.42 |
| Beta | 1.06 |
| Volatility | 17.57% |
| Current Volume | 24.9k |
| Average Volume 20d | 13.3k |
What is the price of XHE stocks?
As of January 23, 2025, the stock is trading at USD 94.29 with a total of 24,900 shares traded.
Over the past week, the price has changed by +3.73%, over one month by +5.88%, over three months by +7.88% and over the past year by +10.94%.
As of January 23, 2025, the stock is trading at USD 94.29 with a total of 24,900 shares traded.
Over the past week, the price has changed by +3.73%, over one month by +5.88%, over three months by +7.88% and over the past year by +10.94%.
Is SPDR S&P Health Care a good stock to buy?
Neither. Based on ValueRay Analyses, SPDR S&P Health Care is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 2.44 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XHE as of January 2025 is 85.57. This means that XHE is currently overvalued and has a potential downside of -9.25%.
Neither. Based on ValueRay Analyses, SPDR S&P Health Care is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 2.44 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XHE as of January 2025 is 85.57. This means that XHE is currently overvalued and has a potential downside of -9.25%.
Is XHE a buy, sell or hold?
SPDR S&P Health Care has no consensus analysts rating.
SPDR S&P Health Care has no consensus analysts rating.
What are the forecast for XHE stock price target?
According to ValueRays Forecast Model, XHE SPDR S&P Health Care will be worth about 95.3 in January 2026. The stock is currently trading at 94.29. This means that the stock has a potential upside of +1.11%.
According to ValueRays Forecast Model, XHE SPDR S&P Health Care will be worth about 95.3 in January 2026. The stock is currently trading at 94.29. This means that the stock has a potential upside of +1.11%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 95.3 | 1.1% |